NCT05348889 2025-02-13First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic MalignanciesChimagen Biosciences, LtdPhase 1/2 Terminated7 enrolled
NCT03312205 2019-01-09CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid MalignanciesHebei Senlang Biotechnology Inc., Ltd.Phase 1/2 Unknown50 enrolled